摘要
随着视网膜母细胞瘤（RB）治疗技术的明显进展,更多患者有机会在生命面临极小风险的前提下得以保存眼球和视功能.尽管目前有冷冻、激光光凝、全身化疗、眼球摘除手术以及通过眼内、球周和眼动脉介入途径的局部化疗等多种治疗方式可供选择,但要形成合理的治疗方案并取得良好疗效仍有些许要点需要考虑.如明确RB是不是眼内期、眼内期肿瘤是选择保眼治疗还是眼球摘除、保眼治疗在何种情况联合化疗、如何安排RB患者的随诊及后续治疗等.在实际临床工作中,制定RB治疗方案时要面临的问题可能更为复杂,应全面综合地评估患者病情、社会经济状况、就诊条件等具体情况,必须明确任何治疗均应遵循保生命为前提的保眼、挽救视功能这一RB治疗原则.
Thanks to the treatment of retinoblastoma （RB） having improved significantly in recent years,there is an increasing trend to use conservative treatment modalities that aim to preserve the globe as well as vision with minimum mortality.RB therapy is a long-term systemic treatment in clinical practice.Although there are many treatment options for RB therapy,such as cryotherapy,photocoagulation,systemic chemotherapy,enucleation and ophthalmic chemotherapy,it is recommended to consider in accordance with the following key points in gaining a reasonable treatment strategies：to make sure that RB is an intraocular period;to determine whether the intraocular RB to be treated with eye preservation or enucleation;what is the case of eye preservation therapy combined with chemotherapy and how to arrange the follow-up of RB patients.It＇s more complicated to choice the therapeutic measures for RB in clinical practice.So,the patient＇s condition,economic capability and medical condition should be evaluated comprehensively.The principle of RB treatment should be followed,which is protecting eyeball and visual function without life damage.
作者
梁建宏
Liang Jianhong(Department of Ophthalmology, Peking University People＇s Hospita;Key Laboratory of Vision Loss and Restoration, Ministry of Educatio;Beijing Key Laboratory for the Diagnosis and Treatment of Retinal and Choroid Diseases, Beijing 100044, Chin)
出处
《中华眼底病杂志》
CAS
CSCD
北大核心
2018年第3期208-211,共4页
Chinese Journal of Ocular Fundus Diseases
